Updated Results of TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathological Complete Response to Pertuzumab and Trastuzumab in Breast Cancer

PURPOSE: Predictive biomarkers to identify patients with human epidermal growth factor receptor 2 (HER2)–positive breast cancer who may benefit from targeted therapy alone are required. We hypothesized that early measurements of tumor maximum standardized uptake value corrected for lean body mass (S...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Connolly, Roisin M., Leal, Jeffrey P., Solnes, Lilja, Huang, Chiung-Yu, Carpenter, Ashley, Gaffney, Katy, Abramson, Vandana, Carey, Lisa A., Liu, Minetta C., Rimawi, Mothaffar, Specht, Jennifer, Storniolo, Anna Maria, Valero, Vicente, Vaklavas, Christos, Krop, Ian E., Winer, Eric P., Camp, Melissa, Miller, Robert S., Wolff, Antonio C., Cimino-Mathews, Ashley, Park, Ben H., Wahl, Richard L., Stearns, Vered
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer Health 2021
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8260904/
https://ncbi.nlm.nih.gov/pubmed/33999652
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.21.00280
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados